Transmission Dynamics of Carbapenemase Genes in CREC: Insigh
2026-08-04
This study provides a detailed molecular epidemiological analysis of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong, China. Key innovations include mapping the prevalence, genetic carriers, and transmission patterns of blaNDM-1 and related resistance determinants, offering actionable insights for antimicrobial resistance surveillance and laboratory assay development.
Methicillin Sodium Salt: Precision in MSSA Infection Models
2026-08-04
Methicillin sodium salt is the gold standard for distinguishing MSSA from MRSA, enabling accurate and reproducible infection models in both clinical and laboratory settings. This article details optimized workflows, troubleshooting strategies, and benchmarks tailored for Staphylococcus aureus infection research.
Methicillin Sodium Salt: Workflow Optimization for MSSA Rese
2026-08-03
Methicillin sodium salt stands as a benchmark tool for modeling gram-positive bacterial infections and dissecting resistance mechanisms in Staphylococcus aureus. This article details evidence-based workflows, troubleshooting strategies, and advanced use cases that maximize the reproducibility and interpretability of MSSA experiments using APExBIO’s high-purity Methicillin sodium salt.
Ceftolozane Sulfate: Translational Dynamics and Precision Do
2026-08-03
Explore the translational science behind Ceftolozane sulfate, focusing on advanced pharmacokinetic/pharmacodynamic modeling, precision dosing, and its robust bactericidal activity against Pseudomonas aeruginosa. This article uniquely bridges animal model insights with clinical assay optimization for resistant infections.
Ceftolozane-Tazobactam in Nosocomial Pneumonia: Evidence and
2026-08-02
The referenced study systematically evaluates ceftolozane-tazobactam as an alternative to carbapenems for nosocomial pneumonia, focusing on activity against multidrug-resistant Pseudomonas aeruginosa and Enterobacteriaceae. Its findings clarify molecular mechanisms of action and clinical performance, informing resistance management and experimental model design.
Vancomycin Hydrochloride: Applied Workflows in Resistance As
2026-08-01
Vancomycin hydrochloride from APExBIO stands apart as a gold-standard glycopeptide antibacterial agent for precision antibiotic resistance assays, selective media design, and translational infection models. This article delivers actionable protocols, advanced troubleshooting, and bridges foundational research into practical, high-impact laboratory workflows.
3-Deazaadenosine Hydrochloride SKU B8470: Reproducibility in
2026-07-31
This scenario-driven article explores how 3-Deazaadenosine hydrochloride (SKU B8470) enables reproducible, sensitive, and robust workflows in cell viability, proliferation, and methylation research. Drawing from recent evidence and peer-reviewed protocols, we address common laboratory challenges, positioning SKU B8470 as a reliable choice for methylation pathway interrogation and hepatic stellate cell studies.
Repurposing FDA Drugs to Inhibit MERS-CoV: de Wilde et al. I
2026-07-31
de Wilde et al. systematically screened 348 FDA-approved compounds, identifying four agents with potent inhibitory effects against MERS-CoV in cell culture. Their findings highlight the translational value of drug repurposing for emerging viral threats and provide a foundation for rapid therapeutic development.
XXLP Modulates NOX2/ROS/Mitochondria/NLRP3 Axis in Ulcerativ
2026-07-30
Xu Chunfu’s Modified Xianglian Pill (XXLP) demonstrates significant therapeutic potential for ulcerative colitis by targeting the NOX2/ROS/mitochondria/NLRP3 axis and modulating gut microbiota. The study’s integration of proteomics, molecular docking, and microbiome analysis advances mechanistic understanding and may inform novel interventions for inflammatory bowel diseases.
Hexetidine (NSC-17764): Experimental Mastery in Oral Biofilm
2026-07-30
Hexetidine (NSC-17764) empowers researchers to dissect and control oral microbial communities with precision, thanks to its strain-specific activity and robust in vitro versatility. This guide translates mechanistic evidence and peer-reviewed protocols into actionable workflows, troubleshooting tips, and comparative insights for advanced biofilm and plaque studies.
Meropenem: Molecular Insights and Resistance Dynamics in Mod
2026-07-29
Explore Meropenem, a β-lactam antibiotic carbapenem, through an advanced scientific lens—unpacking its molecular action, resistance gene transmission, and the latest research implications for Gram-negative and Gram-positive bacterial studies. This unique review integrates cutting-edge evidence and practical guidance for experimental design.
Chloroquine in Precision Research: Pharmacogenomics and Beyo
2026-07-29
Explore how Chloroquine, a 4-aminoquinoline anti-inflammatory agent, is revolutionizing precision research through its unique pharmacogenomic considerations and multi-targeted mechanisms. This in-depth guide analyzes advanced applications and decision-making insights for scientists seeking more than standard autophagy inhibition.
iPSC-Derived Organoids Advance Multilineage Hepatitis E Viru
2026-07-28
The reference study establishes induced pluripotent stem cell (iPSC)-derived liver, intestinal, and brain organoids as robust models for propagating multiple hepatitis E virus (HEV) genotypes. This innovation enables comprehensive investigation of HEV pathogenesis and antiviral strategies in tissue-specific human systems, overcoming major limitations of traditional in vitro and animal models.
Hexetidine (NSC-17764): Strategic Insight for Oral Infection
2026-07-28
This thought-leadership article offers translational researchers a mechanistic, experimental, and workflow-driven perspective on Hexetidine (NSC-17764) as a broad-spectrum antimicrobial agent for oral infection models. Moving beyond standard product information, the article interweaves molecular rationale, quantitative validation, and protocol strategies, and positions Hexetidine within the evolving clinical and research landscape. It also clarifies Hexetidine's limitations in antiviral contexts, referencing the latest peer-reviewed findings.
Human NPT1 as a Renal Apical Transporter for Organic Anions
2026-07-27
This study uncovers the molecular mechanism by which human NPT1, an inorganic phosphate transporter, mediates transport of organic anions—including clinically relevant β-lactam antibiotics like faropenem—across the renal apical membrane. These findings clarify longstanding questions in renal pharmacology, informing antibiotic disposition and resistance research.
466 records 10/32 page Previous Next First page 上5页 678910 下5页 Last page